Microfluidics Market: Growth, Size, Share, and Trends

Report Code AST 7541
Published in Oct, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application (Diagnostics (Clinical, PoC), Research (Proteomic, Genomics, Cell), Therapeutics (Drug Delivery, Wearables)), End User- Global Forecast to 2029

Overview

The global microfluidics market growth forecasted to transform from USD 22.43 Billion in 2024 to USD 32.67 Billion by 2029, driven by a CAGR of 7.8%. Several significant reasons are driving the growth of this market, enhancing its expansion and application. Rising demand for point-of-care diagnostics, where there is a requirement for fast, accurate and cost-efficient instruments. Moreover, the trend toward personalized medicine raises the requirement for precise biomarker analysis and high-throughput screening. Increase in research & development expenditure supports research and investigation of novel and innovative technologies, which further supports market growth.

Attractive Opportunities in the Microfluidics Market

North America

The rising demand of point-of-care testing and increase in expenditure for R&D in microfluidics will play a vital role in market growth in North America.

The development of novel and innovative products and company initiatives, such as partnerships, product launch, approvals and acquisitions, have supported market growth.

The growing adoption of innovative technologies such as digital microfluidics and 3D-inkjet printing is an emerging opportunity for prominent market players.

North America holds the largest share of 40.8% of the sports medicine market in 2023.

Market growth will be supported by increase in prevalence of chronic diseases and integration of microfluidics with diagnostic kits and assays.

Global Microfluidics Market Dynamics

Driver: Rise in prevalence of chronic diseases

The market for microfluidics is affected by growing prevalence of chronic diseases, which increases the requirement for sophisticated diagnostic tools. Microfluidic technologies offer consistent evaluation and accurate management of chronic diseases such as diabetes, cardiovascular problems, and cancer. Microfluidic devices also analyse biological samples at a faster rate with improved precision and accuracy in a cost-efficient manner, which makes it possible to detect such conditions. Due to their ability to handle small volumes of sample and carrying out assays, they are advantageous in the management of chronic diseases, where quick intervention can enhance patient quality of life. The need for efficient diagnostic tools integrated with microfluidics, is rising as the prevalence of chronic diseases increases and thus, supporting market expansion.

Restraint: Technical complexity associated with microfluidics technology

The technological complexity of microfluidics is a major hurdle in its advancement. The design and fabrication of microfluidic devices are complex processes requiring precise production methods and advanced engineering expertise. These devices usually need precise fluid control systems, intricate component integration, and complex channel architectures—all of which might be challenging to achieve. In addition, the need for specific materials and complex fabrication techniques complicates the development process. Because of these technologies' complexity, which drives up manufacturing costs and demands a high level of knowledge, fewer organizations can develop and apply them. Thus, the technological challenges associated with microfluidics may hinder innovation and slow the pace of advancement in several fields, including research, medicine administration, and diagnostics.

 

Opportunities: Digital Microfluidics can broaden the reach of microfluidics

Digital microfluidics has the potential to significantly broaden the field of microfluidics since it offers a more adaptable and easily available platform for a variety of applications. Unlike traditional microfluidics that relies on fixed channels to regulate fluid flow, digital microfluidics requires electric fields to accurately manage individual droplets on an open surface. This flexibility allows for simpler designs and faster prototyping, which removes the need for complex fabrication processes. Affordable point-of-care diagnostics made possible by digital microfluidics could enable prompt testing for diseases like tuberculosis and malaria in developing nations like India, where access to quality healthcare is crucial. Furthermore, academic institutions and small and medium-sized firms (SMEs) can more readily enter the market by simplifying the design and operation of these systems.

Challenges: Limited adoption and awareness of microfluidic devices

A lack of acceptance and knowledge of these technologies significantly hinders the expansion and development of microfluidic devices. Despite its potential to transform several industries, including drug development, diagnostics, and environmental monitoring, microfluidic devices are not yet extensively used. One reason for this limitation is that there is a general lack of understanding of the benefits and applications of the technology. Particularly in less technologically advanced areas, many potential consumers may not be completely aware of the advantages offered by microfluidics, such as reduced sample volumes and faster processing times. In addition, the initial price of these devices and the technical expertise required for maintenance and implementation may deter organizations from deploying them.

Global Microfluidics Market Ecosystem Analysis

Major companies in this market include well-established and financially stable suppliers of microfluidics. Prominent companies in this market include Abbott laboratories (US) , Agilent Technologies, Inc. (US), Aignep S.P.A (Italy), biomerieux (France), BD(US), Bio-Rad laboratories, Inc (US), Danaher Corporation (US), Illumina Inc. (US), Parker Hannifin Coporation (US), Thermo Fisher Scientific Inc. (US), SMC Corporation (Japan), Idex Corporation (US), Fortive Corporation (US), Perkinelmer, Inc. (US), F.Hoffmann-LA Roche Ltd (Switzerland), Standard Biotools Inc. (US), Quidelortho Corporation (US), Hologic Inc. (US), Dolomite Microfluidics (UK) and Elveflow (France).

 

Microfluidic chips to register largest market share in 2024

Based on type, microfluidics components have been categorized into numerous subsegments such as microfluidic Chip, flow and pressure sensors, flow and pressure sensors, micropumps, microfluidic valves, microneedles and other microfluidic components. Among them, microfluidic Chip has the largest microfluidics market share. Microfluidic chips are mini devices that use etched channels and chambers in a substrate to regulate fluids at the microscale range. These chips have made it easier to accurately regulate and assess small fluid volume in the range of microliters or nanoliters. Due to their applications in pharmaceuticals, environmental monitoring, and healthcare, they hold the largest market share in microfluidics. They offer quick, high-throughput processing with efficacy, which is important for drug development and diagnostics. As compared to conventional methods, they are less expensive as they need less amount of reagent and sample volumes.

Polymethyl Metacrylate to register the highest CAGR during the forecast period

Polymers has been classified into polymethyl metacrylate, polymethyl siloxane, cyclic olefin copolymers and other polymers. Among them, polymethyl metacrylate (PMMA) is expected to reach the highest CAGR during the forecast period. PMMA stands for polymethyl methacrylate, a lightweight polymer that is used in microfluidics due to its superior optical clarity and resistance to chemicals. The market for microfluidics is rising at a faster pace due to PMMA's potential to develop complicated and accurate microchannels and chambers that are important for efficient fluid regulation. It can be utilized with common microfabrication methods such as injection molding and heat embossing. It is a cheaper option for developing high-quality microfluidic devices. Furthermore, PMMA's ability to adapt in chemical conditions and ease of bonding with other substances are increasing its application in microfluidic , from drug delivery to research to diagnostics.

Hospitals and Diagnostic Centers hold the largest share of the end-user market during the forecast period

Due to their potential to generate requirement for advanced diagnostic and analytical techniques, hospitals and diagnostic centers are key players in the microfluidics market. Faster, precise and efficient testing is carried out by microfluidic devices, which is important in healthcare settings where faster results can affect patient care largely. These instruments offer precise, high-throughput results with less volume of sample for numerous uses, such as point-of-care testing, and disease diagnostics. Improved patient outcomes result from the application of microfluidics into workflows, which enhances the potential to conduct intricate assays and screenings. Hospitals and diagnostic centers play a significant role in the expansion and advancement of the microfluidics market due to their increasing application of microfluidic technologies.

Asia Pacific to account for a significant market share in the microfluidics market

For several significant reasons, the microfluidics market in the Asia-Pacific region is expanding. First, the market is growing because of the industry's rapid infrastructure development in this region and the growing demand for advanced diagnostic and analytical technologies. The countries in this region are heavily investing in the advancement of their healthcare systems and the application of innovative medical technologies, like microfluidic devices. The growing prevalence of chronic disorders and the need for efficient diagnostic instruments are further propelling the growth of this market. The region has strong manufacturing capacity and can provide microfluidic technology at an affordable rate. Moreover, significant research and development initiatives, when combined with supportive financial help and governmental policies, foster innovation and accelerate market growth.

HIGHEST CAGR MARKET IN 2024

Recent Developments of Microfluidics Market

  • In 2024, Illumina. Inc. (US) acquired Fluent BioSciences (US) to enhance its ability for single-cell analysis.
  • In 2023, Danaher Corporation (US) acquired Abcam plc (UK) to expand its reach in the proteomics area.

Key Market Players

KEY PLAYERS IN THE MICROFLUIDICS MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Microfluidics Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value (USD Million/USD Billion)
Segments covered Product, Application, End User, and Region
Geographies covered North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Key Questions Addressed by the Report

What will be the addressable market value of the global microfluidics market within five years?
The Microfluidics market is projected to reach USD 32.67 Billion by 2029 from USD 22.43 in 2024, growing at a CAGR of 7.8% during the forecast period.
Which product type segments have the highest potential for growth in the microfluidics market?
Microfluidics-based devices are expected to exhibit the highest growth rates.
What are the major strategies adopted by leading players to enter emerging regions?  
Agreements, partnerships, collaboration, expansion, product launches, and product approvals represent the major growth strategies adopted by major market players.
What are the major factors likely to hamper the growth of the microfluidics market?
High development costs, integration issues with conventional equipment and limited adoption can hamper the growth of the microfluidics market.
Which end-user segment will likely show the highest growth in the microfluidics market?
Hospitals and diagnostic centers are expected to grow at the highest rate in the end-user market.

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Microfluidics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
30
RESEARCH METHODOLOGY
36
EXECUTIVE SUMMARY
50
PREMIUM INSIGHTS
54
MARKET OVERVIEW
57
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Growing requirement for point-of-care testing
    - Rising technological advancements
    - Increasing focus on data precision and accuracy
    - Economic benefits associated with microfluidics
    - Portability with microfluidic chip miniaturization
    - Rising demand for effective sample analysis
    RESTRAINTS
    - Stringent regulatory approval process
    - Integration of microfluidics into current workflow
    OPPORTUNITIES
    - Emergence of 3D cell culture systems
    - Growth potential of emerging economies
    - Use of microfluidics in life sciences & pharmaceutical industries
    CHALLENGES
    - Low adoption of microfluidic devices among end users
  • 5.3 INDUSTRY TRENDS
    E-HEALTH DIAGNOSTICS
    INTEGRATION OF MICROFLUIDICS WITH 3D PRINTING
    R&D INVESTMENTS FOR PRODUCT DEVELOPMENT
  • 5.4 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.5 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.6 REGULATORY LANDSCAPE
    NORTH AMERICA
    - US
    - Canada
    EUROPE
    ASIA PACIFIC
    - Japan
    - China
    - India
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.7 REIMBURSEMENT SCENARIO
  • 5.8 ECOSYSTEM ANALYSIS
  • 5.9 VALUE CHAIN ANALYSIS
    RESEARCH & DEVELOPMENT
    RAW MATERIAL PROCUREMENT & MANUFACTURING
    MARKETING & SALES, DISTRIBUTION, AND POST-SALES SERVICES
  • 5.10 SUPPLY CHAIN ANALYSIS
  • 5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.12 IMPACT OF GEN AI ON MICROFLUIDICS MARKET
  • 5.13 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS FOR MICROFLUIDICS
    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.14 TRADE ANALYSIS
    IMPORT DATA
    EXPORT DATA
  • 5.15 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Biosensor elements
    - Materials science
    - Microfabrication
    - Direct-writing
    COMPLEMENTARY TECHNOLOGIES
    - MEMS
    ADJACENT TECHNOLOGIES
    - 3D inkjet printing
    - Lab-on-fiber
  • 5.16 KEY CONFERENCES & EVENTS
  • 5.17 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND, BY REGION
    AVERAGE SELLING PRICE TREND OF TOP 3 APPLICATIONS, BY KEY PLAYER
  • 5.18 UNMET NEEDS/END-USER EXPECTATIONS IN MICROFLUIDICS MARKET
  • 5.19 CASE STUDY ANALYSIS
    CASE STUDY 1: MULTIPLEX MICROFLUIDIC CIRCUIT FOR BLOOD VESSEL-ON-A-CHIP PERFUSION USING FLOWEZ
    CASE STUDY 2: MICROFLUIDIC SYSTEM FOR ROBOTIC HAND PLAYING NINTENDO
    CASE STUDY 3: 3D-PRINTED MICROFLUIDIC DEVICES USING POLYJET TECHNOLOGY
  • 5.20 INVESTMENT & FUNDING SCENARIO
MICROFLUIDICS MARKET, BY PRODUCT
110
  • 6.1 INTRODUCTION
  • 6.2 MICROFLUIDICS-BASED DEVICES
    HIGH UPTAKE OF POC TESTING AND ORGAN-ON-A-CHIP SYSTEMS TO PROPEL MARKET
  • 6.3 MICROFLUIDIC COMPONENTS
    MICROFLUIDIC COMPONENTS, BY TYPE
    - Microfluidic chips
    - Flow & pressure sensors
    - Flow & pressure controllers
    - Microfluidic valves
    - Micropumps
    - Microneedles
    - Other microfluidic components
    MICROFLUIDIC COMPONENTS, BY MATERIAL
    - Silicon
    - Polymers
    - Glass
MICROFLUIDICS MARKET, BY APPLICATION
134
  • 7.1 INTRODUCTION
  • 7.2 IVD
    CLINICAL DIAGNOSTICS
    - Growing focus on early disease detection to drive market
    POINT-OF-CARE TESTING (POCT)
    - High uptake of lab-on-a-chip technologies to fuel uptake
    VETERINARY DIAGNOSTICS
    - Detection of toxins in food through LOC systems to support market growth
  • 7.3 PHARMACEUTICAL & LIFE SCIENCE RESEARCH
    LAB ANALYTICS
    - Proteomic analysis
    - Genomic analysis
    - Cell-based assays
    - Capillary electrophoresis
    MICRODISPENSING
    - Suitability for low-viscosity applications to support market growth
    MICROREACTORS
    - High uptake by leading companies for process optimization to fuel market
  • 7.4 THERAPEUTICS
    DRUG DELIVERY
    - Utilization of microneedles for painless and precise delivery to drive market
    WEARABLE DEVICES
    - Integration of microfluidics-based wearable devices to support market growth
MICROFLUIDICS MARKET, BY END USER
152
  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS AND DIAGNOSTIC CENTERS
    AVAILABILITY OF TECHNOLOGICALLY ADVANCED EQUIPMENT AND FOCUS ON EARLY DISEASE DIAGNOSIS TO BOOST DEMAND
  • 8.3 ACADEMIC & RESEARCH INSTITUTES
    INVESTMENTS IN BIOMEDICAL & LIFE SCIENCE RESEARCH TO SUPPORT MARKET GROWTH
  • 8.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    GROWING FOCUS ON BIOMARKER & DRUG DISCOVERY TO PROPEL MARKET
MICROFLUIDICS MARKET, BY REGION
159
  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - High healthcare expenditure and wide adoption of technologically advanced products to drive market
    CANADA
    - Government funds and focus on research to support market growth
  • 9.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Growing focus on proteomics & genomics research to drive market
    FRANCE
    - Favorable government support for R&D to drive market
    UK
    - Rising cases of chronic diseases and increasing demand for POC testing to boost demand
    ITALY
    - Innovative development of microfluidic chips to boost demand
    SPAIN
    - Growth in pharmaceutical industry to fuel uptake
    REST OF EUROPE
  • 9.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    - Growing focus on nanotechnology to drive market
    JAPAN
    - High investments in academic research activities to propel market
    INDIA
    - Increasing prevalence of CVD and diabetes to support market growth
    AUSTRALIA
    - Rising incidence of infectious diseases to fuel uptake
    SOUTH KOREA
    - Increasing R&D expenditure to drive growth
    REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Increasing development of disease diagnostics kits to fuel uptake
    MEXICO
    - Rising prevalence of chronic diseases to boost demand for POC testing
    REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Adoption of advanced microfluidic devices to support market growth
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
160
  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 10.3 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MICROFLUIDICS MARKET
  • 10.4 REVENUE ANALYSIS
  • 10.5 MARKET SHARE ANALYSIS BY KEY PLAYERS,2023
  • 10.6 RANKING OF KEY MARKET PLAYERS
  • 10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Product footprint
    - Application footprint
    - End-user footprint
    - Region footprint
  • 10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    - Detailed list of key startup/SME players
    - Competitive benchmarking of key emerging players/startups
  • 10.9 COMPANY VALUATION & FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 10.10 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • 10.11 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & APPROVALS
    DEALS
    EXPANSIONS
    OTHER DEVELOPMENTS
COMPANY PROFILES
250
  • 11.1 KEY PLAYERS
    DANAHER CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ILLUMINA, INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BIOMÉRIEUX
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ABBOTT LABORATORIES
    - Business overview
    - Products offered
    - MnM view
    PARKER HANNIFIN CORP
    - Business overview
    - Products offered
    SMC CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    IDEX CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    FORTIVE
    - Business overview
    - Products offered
    PERKINELMER INC.
    - Business overview
    - Products offered
    - Recent developments
    AGILENT TECHNOLOGIES, INC.
    - Business overview
    - Products offered
    - Recent developments
    BIO-RAD LABORATORIES, INC.
    - Business overview
    - Products offered
    - Recent developments
    BECTON, DICKINSON AND COMPANY
    - Business overview
    - Products offered
    - Recent developments
    F. HOFFMANN-LA ROCHE LTD.
    - Business overview
    - Products offered
    - Recent developments
    STANDARD BIOTOOLS
    - Business overview
    - Products offered
    - Recent developments
    QUIDELORTHO CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    HOLOGIC, INC.
    - Business overview
    - Products offered
    - Recent developments
    AIGNEP S.P.A.
    - Business overview
    - Products offered
    - Recent developments
    DOLOMITE MICROFLUIDICS
    - Business overview
    - Products offered
    - Recent developments
    ELVEFLOW
    - Business overview
    - Products offered
  • 11.2 OTHER PLAYERS
    NANOSTRING TECHNOLOGIES
    NORTIS INC.
    INNOVATIVE BIOCHIPS, LLC
    FLUIDIC ANALYTICS
    UFLUIDIX
    HORIBA
    MICRONIT B.V.
APPENDIX
351
  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 MICROFLUIDICS MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 MICROFLUIDICS MARKET: STUDY ASSUMPTIONS
  • TABLE 3 RISK ASSESSMENT: MICROFLUIDICS MARKET
  • TABLE 4 PRODUCT LAUNCHES BY KEY PLAYERS, 2023
  • TABLE 5 LIST OF UNIVERSITY STARTUPS IN MICROFLUIDICS MARKET
  • TABLE 6 MICROFLUIDICS MARKET: PORTER’S FIVE FORCES
  • TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROFLUIDICS MARKET
  • TABLE 8 KEY BUYING CRITERIA FOR MICROFLUIDICS MARKET, BY MATERIAL
  • TABLE 9 US: CLASSIFICATION OF MICROFLUIDICS TECHNOLOGY-ASSOCIATED DIAGNOSTIC DEVICES
  • TABLE 10 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION
  • TABLE 11 EUROPE: CLASSIFICATION OF MICROFLUIDICS ASSOCIATED WITH IVD DEVICES
  • TABLE 12 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION
  • TABLE 13 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION
  • TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 MAJOR CPT CODES FOR DIAGNOSTICS TESTS IN US, 2023
  • TABLE 20 MICROFLUIDICS MARKET: ROLE IN ECOSYSTEM
  • TABLE 21 APPLICATIONS OF ARTIFICIAL INTELLIGENCE-POWERED MICROFLUIDICS
  • TABLE 22 LIST OF MAJOR PATENT INNOVATIONS AND PATENT REGISTRATIONS, 2022–2024
  • TABLE 23 IMPORT DATA FOR HS CODE 3822, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 24 EXPORT DATA FOR HS CODE 3822, BY COUNTRY, 2019−2023 (USD THOUSAND)
  • TABLE 25 MICROFLUIDICS MARKET: KEY CONFERENCES & EVENTS (2023–2024)
  • TABLE 26 AVERAGE SELLING PRICE OF MICROFLUIDICS MEDICINE EQUIPMENT, BY REGION, 2023 (USD THOUSAND)
  • TABLE 27 AVERAGE SELLING PRICE OF TOP 3 APPLICATIONS, BY KEY PLAYER, 2023 (USD)
  • TABLE 28 MICROFLUIDICS MARKET: CURRENT UNMET NEEDS
  • TABLE 29 CASE STUDY 1: MULTIPLEX MICROFLUIDIC CIRCUIT FOR BLOOD VESSEL-ON-A-CHIP PERFUSION USING FLOWEZ
  • TABLE 30 CASE STUDY 2: MICROFLUIDIC SYSTEM FOR ROBOTIC HAND PLAYING NINTENDO
  • TABLE 31 CASE STUDY 3: 3D-PRINTED MICROFLUIDIC DEVICES USING POLYJET TECHNOLOGY
  • TABLE 32 MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 33 MICROFLUIDICS-BASED DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 34 MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 35 MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 36 MICROFLUIDIC CHIPS OFFERED BY KEY PLAYERS
  • TABLE 37 MICROFLUIDIC CHIPS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 38 FLOW & PRESSURE SENSORS OFFERED BY KEY PLAYERS
  • TABLE 39 FLOW & PRESSURE SENSORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 40 FLOW & PRESSURE CONTROLLERS OFFERED BY KEY PLAYERS
  • TABLE 41 FLOW & PRESSURE CONTROLLERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 42 MICROFLUIDIC VALVES OFFERED BY KEY PLAYERS
  • TABLE 43 MICROFLUIDIC VALVES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 44 MICROPUMPS OFFERED BY KEY PLAYERS
  • TABLE 45 MICROPUMPS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 46 MICRONEEDLES OFFERED BY KEY PLAYERS
  • TABLE 47 MICRONEEDLES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 48 OTHER MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 49 MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 50 SILICON-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 51 POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 52 POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 53 PMMA-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 54 PDMS-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 55 COC-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 56 OTHER POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 57 GLASS-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 58 MICROFLUIDICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 59 MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 60 MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 61 MICROFLUIDICS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 62 MICROFLUIDICS MARKET FOR POCT, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 63 MICROFLUIDICS MARKET FOR VETERINARY DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 64 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 65 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 66 MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 67 MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 68 MICROFLUIDICS MARKET FOR PROTEOMIC ANALYSIS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 69 MICROFLUIDICS MARKET FOR GENOMIC ANALYSIS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 70 MICROFLUIDICS MARKET FOR CELL-BASED ASSAYS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 71 MICROFLUIDICS MARKET FOR CAPILLARY ELECTROPHORESIS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 72 MICROFLUIDICS MARKET FOR MICRODISPENSING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 73 MICROFLUIDICS MARKET FOR MICROREACTORS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 74 MICROFLUIDICS MARKET FOR THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 75 MICROFLUIDICS MARKET FOR THERAPEUTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 76 MICROFLUIDICS MARKET FOR DRUG DELIVERY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 77 MICROFLUIDICS MARKET FOR WEARABLE DEVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 78 MICROFLUIDICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 79 MICROFLUIDICS MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 80 LEADING MICROFLUIDICS RESEARCH INSTITUTES, BY AREA OF INTEREST
  • TABLE 81 MICROFLUIDICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 82 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 83 MICROFLUIDICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 84 NORTH AMERICA: MACROECONOMIC OUTLOOK
  • TABLE 85 NORTH AMERICA: MICROFLUIDICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 86 NORTH AMERICA: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 87 NORTH AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 88 NORTH AMERICA: MICROFLUIDICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 89 NORTH AMERICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 90 NORTH AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 91 NORTH AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 92 NORTH AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 93 NORTH AMERICA: MICROFLUIDICS COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 94 NORTH AMERICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 95 NORTH AMERICA: MICROFLUIDICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 96 US: KEY MACROINDICATORS
  • TABLE 97 US: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 98 US: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 99 US: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 100 US: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 101 CANADA: KEY MACROINDICATORS
  • TABLE 102 CANADA: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 103 CANADA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 104 CANADA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 105 CANADA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 106 EUROPE: MACROECONOMIC OUTLOOK
  • TABLE 107 EUROPE: MICROFLUIDICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 108 EUROPE: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 109 EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 110 EUROPE: MICROFLUIDICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 111 EUROPE: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 112 EUROPE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 113 EUROPE: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 114 EUROPE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 115 EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 116 POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 117 EUROPE: MICROFLUIDICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 118 GERMANY: KEY MACROINDICATORS
  • TABLE 119 GERMANY: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 120 GERMANY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 121 GERMANY: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 122 GERMANY: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 123 FRANCE: KEY MACROINDICATORS
  • TABLE 124 FRANCE: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 125 FRANCE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 126 FRANCE: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 127 FRANCE: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 128 UK: KEY MACROINDICATORS
  • TABLE 129 UK: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 130 UK: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 131 UK: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 132 UK: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 133 ITALY: KEY MACROINDICATORS
  • TABLE 134 ITALY: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 135 ITALY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 136 ITALY: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 137 ITALY: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 138 SPAIN: KEY MACROINDICATORS
  • TABLE 139 SPAIN: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 140 SPAIN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 141 SPAIN: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 142 SPAIN: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 143 REST OF EUROPE: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 144 REST OF EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 145 REST OF EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 146 REST OF EUROPE: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: MACROECONOMIC INDICATORS
  • TABLE 148 ASIA PACIFIC: MICROFLUIDICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: MICROFLUIDICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 154 ASIA PACIFIC: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 155 ASIA PACIFIC: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 156 ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 157 ASIA PACIFIC: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 158 ASIA PACIFIC: MICROFLUIDICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 159 CHINA: KEY MACROINDICATORS
  • TABLE 160 CHINA: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 161 CHINA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 162 CHINA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 163 CHINA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 164 JAPAN: KEY MACROINDICATORS
  • TABLE 165 JAPAN: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 166 JAPAN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 167 JAPAN: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 168 JAPAN: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 169 INDIA: KEY MACROINDICATORS
  • TABLE 170 INDIA: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 171 INDIA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 172 INDIA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 173 INDIA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 174 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 175 AUSTRALIA: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 176 AUSTRALIA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 177 AUSTRALIA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 178 AUSTRALIA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 179 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 180 SOUTH KOREA: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 181 SOUTH KOREA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 182 SOUTH KOREA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 183 SOUTH KOREA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 184 REST OF ASIA PACIFIC: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 185 REST OF ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 186 REST OF ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 187 REST OF ASIA PACIFIC: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 188 LATIN AMERICA: MACROECONOMIC OUTLOOK
  • TABLE 189 LATIN AMERICA: MICROFLUIDICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 190 LATIN AMERICA: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 191 LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 192 LATIN AMERICA: MICROFLUIDICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 193 LATIN AMERICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 194 LATIN AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 195 LATIN AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 196 LATIN AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 197 LATIN AMERICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 198 LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 199 LATIN AMERICA: MICROFLUIDICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 200 BRAZIL: KEY MACROINDICATORS
  • TABLE 201 BRAZIL: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 202 BRAZIL: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 203 BRAZIL: MICROFLUIDICS COMPONENT MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 204 BRAZIL: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 205 MEXICO: KEY MACROINDICATORS
  • TABLE 206 MEXICO: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 207 MEXICO: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 208 MEXICO: MICROFLUIDICS MARKET, MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 209 MEXICO: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 210 REST OF LATIN AMERICA: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 211 REST OF LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 212 REST OF LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 213 REST OF LATIN AMERICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 214 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 215 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
  • TABLE 216 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 217 MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 218 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 219 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 220 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 221 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 222 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 223 MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 224 MIDDLE EAST & AFRICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 225 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 226 GCC COUNTRIES: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 227 GCC COUNTRIES: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 228 GCC COUNTRIES: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 229 GCC COUNTRIES: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 230 REST OF MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 231 REST OF MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 232 REST OF MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
  • TABLE 233 REST OF MIDDLE EAST & AFRICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 234 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
  • TABLE 235 MICROFLUIDICS MARKET: DEGREE OF COMPETITION
  • TABLE 236 MICROFLUIDICS MARKET: PRODUCT FOOTPRINT
  • TABLE 237 MICROFLUIDICS MARKET: APPLICATION FOOTPRINT
  • TABLE 238 MICROFLUIDICS MARKET: END-USER FOOTPRINT
  • TABLE 239 MICROFLUIDICS MARKET: REGION FOOTPRINT
  • TABLE 240 MICROFLUIDICS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 241 MICROFLUIDICS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 242 MICROFLUIDICS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 243 MICROFLUIDICS MARKET: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 244 MICROFLUIDICS MARKET: EXPANSIONS, JANUARY 2021–AUGUST 2024
  • TABLE 245 MICROFLUIDICS MARKET: OTHER DEVELOPMENTS, JANUARY 2021−AUGUST 2024
  • TABLE 246 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 247 DANAHER CORPORATION: PRODUCTS OFFERED
  • TABLE 248 DANAHER CORPORATION: DEALS, JANUARY 2021−AUGUST 2024
  • TABLE 249 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021−AUGUST 2024
  • TABLE 250 ILLUMINA, INC.: COMPANY OVERVIEW
  • TABLE 251 ILLUMINA INC.: PRODUCTS OFFERED
  • TABLE 252 ILLUMINA, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 253 ILLUMINA, INC.: DEALS, JANUARY 2021−AUGUST 2024
  • TABLE 254 BIOMÉRIEUX: COMPANY OVERVIEW
  • TABLE 255 BIOMÉRIEUX: PRODUCTS OFFERED
  • TABLE 256 BIOMÉRIEUX: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2024
  • TABLE 257 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 258 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 259 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 260 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 261 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–AUGUST 2024
  • TABLE 262 ABBOTT LABORATORIES: COMPANY OVERVIEW
  • TABLE 263 ABBOTT LABORATORIES: PRODUCTS OFFERED
  • TABLE 264 PARKER HANNIFIN CORP: COMPANY OVERVIEW
  • TABLE 265 PARK HANNIFIN CORP: PRODUCTS OFFERED
  • TABLE 266 SMC CORPORATION: COMPANY OVERVIEW
  • TABLE 267 SMC CORPORATION: PRODUCTS OFFERED
  • TABLE 268 SMC CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 269 IDEX CORPORATION: COMPANY OVERVIEW
  • TABLE 270 IDEX CORPORATION: PRODUCTS OFFERED
  • TABLE 271 IDEX CORPORATION: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 272 FORTIVE: COMPANY OVERVIEW
  • TABLE 273 FORTIVE: PRODUCTS OFFERED
  • TABLE 274 PERKINELMER INC.: COMPANY OVERVIEW
  • TABLE 275 PERKINELMER INC.: PRODUCTS OFFERED
  • TABLE 276 PERKINELMER INC.: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 277 PERKINELMER INC.: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 278 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 279 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
  • TABLE 280 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 281 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 282 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021–AUGUST 2024
  • TABLE 283 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 284 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
  • TABLE 285 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 286 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 287 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
  • TABLE 288 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
  • TABLE 289 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2024
  • TABLE 290 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 291 BECTON, DICKINSON AND COMPANY: EXPANSIONS, JANUARY 2021–AUGUST 2024
  • TABLE 292 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
  • TABLE 293 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
  • TABLE 294 F. HOFFMANN-LA ROCHE LTD: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2024
  • TABLE 295 F. HOFFMANN-LA ROCHE LTD: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 296 STANDARD BIOTOOLS: COMPANY OVERVIEW
  • TABLE 297 STANDARD BIOTOOLS: PRODUCTS OFFERED
  • TABLE 298 STANDARD BIOTOOLS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2024
  • TABLE 299 STANDARD BIOTOOLS: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 300 QUIDELORTHO CORPORATION: COMPANY OVERVIEW
  • TABLE 301 QUIDELORTHO CORPORATION: PRODUCTS OFFERED
  • TABLE 302 QUIDELORTHO CORPORATION: PRODUCT APPROVALS, JANUARY 2021–AUGUST 2024
  • TABLE 303 QUIDELORTHO CORPORATION: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 304 QUIDELORTHO CORPORATION: EXPANSIONS, JANUARY 2021–AUGUST 2024
  • TABLE 305 HOLOGIC, INC.: COMPANY OVERVIEW
  • TABLE 306 HOLOGIC, INC.: PRODUCTS OFFERED
  • TABLE 307 HOLOGIC, INC: PRODUCT APPROVALS, JANUARY 2021–AUGUST 2024
  • TABLE 308 HOLOGIC, INC: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 309 AIGNEP S.P.A.: COMPANY OVERVIEW
  • TABLE 310 AIGNEP S.P.A.: PRODUCTS OFFERED
  • TABLE 311 AIGNEP S.P.A.: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 312 DOLOMITE MICROFLUIDICS: COMPANY OVERVIEW
  • TABLE 313 DOLOMITE MICROFLUIDICS: PRODUCTS OFFERED
  • TABLE 314 DOLOMITE MICROFLUIDICS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2024
  • TABLE 315 DOLOMITE MICROFLUIDICS: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 316 DOLOMITE MICROFLUIDICS: OTHER DEVELOPMENTS, JANUARY 2021−AUGUST 2024
  • TABLE 317 ELVEFLOW: COMPANY OVERVIEW
  • TABLE 318 ELVEFLOW: PRODUCTS OFFERED
  • TABLE 319 NANOSTRING TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 320 NORTIS INC.: COMPANY OVERVIEW
  • TABLE 321 INNOVATIVE BIOCHIPS, LLC: COMPANY OVERVIEW
  • TABLE 322 FLUIDIC ANALYTICS: COMPANY OVERVIEW
  • TABLE 323 UFLUIDIX: COMPANY OVERVIEW
  • TABLE 324 HORIBA: COMPANY OVERVIEW
  • TABLE 325 MICRONIT B.V.: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 MICROFLUIDICS MARKET SEGMENTATION
  • FIGURE 2 MICROFLUIDICS MARKET: RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 7 MICROFLUIDICS MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
  • FIGURE 8 MICROFLUIDICS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 10 TOP-DOWN APPROACH
  • FIGURE 11 DATA TRIANGULATION
  • FIGURE 12 MICROFLUIDICS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 MICROFLUIDICS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 MICROFLUIDICS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 GEOGRAPHICAL SNAPSHOT OF MICROFLUIDICS MARKET, 2024–2029
  • FIGURE 17 GROWING DEMAND FOR POINT-OF-CARE TESTING TO DRIVE MARKET
  • FIGURE 18 HOSPITALS AND DIAGNOSTIC CENTERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE FOR JAPAN IN 2023
  • FIGURE 19 NORTH AMERICA TO DOMINATE MICROFLUIDICS MARKET IN 2024
  • FIGURE 20 CHINA TO ACCOUNT FOR HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 21 MICROFLUIDICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22 GLOBAL CANCER INCIDENCE, 2020−2040
  • FIGURE 23 MICROFLUIDICS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROFLUIDICS MARKET, BY MATERIAL
  • FIGURE 25 KEY BUYING CRITERIA, BY MATERIAL
  • FIGURE 26 US: REGULATORY PROCESS FOR TESTING DEVICES ASSOCIATED WITH MICROFLUIDICS TECHNOLOGY
  • FIGURE 27 CANADA: REGULATORY PROCESS FOR MICROFLUIDICS-ASSOCIATED IVD DEVICES IN CANADA
  • FIGURE 28 EUROPE: REGULATORY PROCESS FOR IVD DEVICES
  • FIGURE 29 INDIA: REGULATORY PROCESS FOR IVD DEVICES
  • FIGURE 30 MICROFLUIDICS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 31 MICROFLUIDICS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 32 MICROFLUIDICS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 33 REVENUE SHIFT AND NEW REVENUE POCKETS
  • FIGURE 34 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR MICROFLUIDICS PATENTS (JANUARY 2014–AUGUST 2024)
  • FIGURE 35 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2021- 2023 (USD)
  • FIGURE 36 AVERAGE SELLING PRICE OF TOP 3 APPLICATIONS, BY KEY PLAYER
  • FIGURE 37 INVESTMENT & FUNDING SCENARIO, 2019−2023
  • FIGURE 38 NUMBER OF INVESTOR DEALS, BY KEY PLAYERS, 2019–2023
  • FIGURE 39 VALUE OF INVESTOR DEALS BY KEY PLAYERS, 2019–2023 (USD MILLION)
  • FIGURE 40 NORTH AMERICA: MICROFLUIDICS MARKET SNAPSHOT
  • FIGURE 41 ASIA PACIFIC: MICROFLUIDICS MARKET SNAPSHOT
  • FIGURE 42 REVENUE ANALYSIS OF KEY PLAYERS IN MICROFLUIDICS MARKET (2019−2023)
  • FIGURE 43 MARKET SHARE ANALYSIS OF KEY PLAYERS IN MICROFLUIDICS MARKET (2023)
  • FIGURE 44 RANKING OF KEY PLAYERS IN MICROFLUIDICS MARKET, 2023
  • FIGURE 45 MICROFLUIDICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 46 MICROFLUIDICS MARKET: COMPANY FOOTPRINT
  • FIGURE 47 MICROFLUIDICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 48 EV/EBITDA OF KEY VENDORS
  • FIGURE 49 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 50 MICROFLUIDICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 51 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 52 ILLUMINA, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 53 BIOMÉRIEUX: COMPANY SNAPSHOT (2023)
  • FIGURE 54 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 55 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023)
  • FIGURE 56 PARKER HANNIFIN CORP: COMPANY SNAPSHOT (2023)
  • FIGURE 57 SMC CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 58 IDEX CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 59 FORTIVE: COMPANY SNAPSHOT (2023)
  • FIGURE 60 PERKINELMER INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 61 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 62 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 63 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023)
  • FIGURE 64 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 65 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2023)
  • FIGURE 66 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 67 HOLOGIC, INC.: COMPANY SNAPSHOT (2023)

Four main studies were done to estimate the market size of microfluidics. Secondary research was carried out to obtain data associated with the market, peer markets, and parent markets. After that, data was obtained from 3-5 secondary sources; the findings, assumptions, and sizing were confirmed through primary sources. Top-down and bottom-up approaches were utilized to gain insights on complete market size. After that, market breakdown and data triangulation were used to determine the market size of segments and subsegments.

Secondary Research

Directories, databases like D&B Hoovers, Factiva, white papers, Bloomberg Businessweek, annual reports, SEC filings, business filings and investor presentations are few of the important sources used in the secondary research. This helps in gaining fundamental details about prominent companies and market segmentation as per the industry trends at numerous levels and technological viewpoints related with the Microfluidics market.

Primary Research

The primary research compromised performing interviews from both the supply and demand sides to obtain quantitative and qualitative data. CEOs, area sales managers, territory sales managers, regional sales managers and other important officials from top businesses are the primary sources from the supply side. Physicians, researchers, department heads, and staff members from diagnostic centers, hospitals and research institutes were the primary sources from the demand side. The target of this study was to verify the conclusions and assumptions from secondary research by interacting with stakeholders directly.

A breakdown of the primary respondents is provided below:

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The revenue share analysis of the major key players for the size of the Microfluidics market is given in this study. Primary and secondary research are used to find prominent players in the Microfluidics and to gain insights of their financials and market share. The primary research approach comprises extremely in-depth interviews with CEOs, directors, and senior marketing executives, while the secondary research procedure mostly relied on the annual and financial reports of major players. Segment-based technique was used to determine the global market value. The revenue details of significant solution and service suppliers was then applied to source these segmented revenues.

The steps in the procedure  are

  • List the key global companies that are associated with the Microfluidics industry. Note the annual revenues of the players in the Microfluidics industry or the product category/business division.
  • As of 2024, it represents an important portion of the market based on revenue mapping of the key competitors. Extrapolation to the global value for the Microfluidics market.

Data Triangulation

The Microfluidics market was categorized into various segments and subsegments with the help of the above procedure. Then, data triangulation and the market segmentation process are carried out to ensure the accuracy of the data for each segment. Factors and trends from demand and supply sides were studied . Top-down and bottom-up approaches provide the outcome from the analysis of the Microfluidics market.

Market Definition

The microfluidics market includes products and technologies that are developed to analyse and regulate fluid volume through microfluidic devices and components. The market covers both the microfluidics components that are important for the working of microfluidics-based devices, such as lab-on-a-chip systems and diagnostic assays, as well as the devices. Microneedles, micropumps, flow and pressure sensors, controllers, and microfluidic valves are some of the important components of microfluidics-based device.Polymers, silicon, and glass are most often used in the development of these components. The market provides innovative technologies for effective and precise fluid management and analysis, which have beneficial applications in research and diagnostics.

Stakeholders

  • Microfluidic product manufacturers
  • Microfluidic product distributors
  • Pharmaceutical companies
  • IVD manufacturers
  • In vitro diagnostic test (IVD) distributors
  • Research institutes
  • Contract manufacturing organizations (CMOs)
  • Contract research organizations (CROs)
  • Healthcare institutions (hospitals, medical schools, and outpatient clinics)
  • Government associations
  • Market research and consulting firms
  • Venture capitalists and investors

Report Objectives

  • To define, describe, and forecast the microfluidics market by product, application, end-user, and region
  • To provide detailed information about the key factors influencing the market growth, such as drivers, restraints, opportunities, challenges, and industry trends
  • To strategically analyze the regulatory scenario, Porter’s five force analysis, value chain analysis, supply chain analysis, ecosystem map, and patent analysis
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the microfluidics market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To profile the prominent players in this market and comprehensively analyze their market shares and core competencies
  • To strategically analyze the microfluidics market in five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To track and analyze competitive developments such as acquisitions, product launches, product approvals, partnerships, and expansions in the microfluidics market

 

Previous Versions of this Report

Microfluidics Market by Product (Device, Component (Chip, Sensor, Microneedle, Pump, Valve), Application (IVD (POC, Clinical, Vet), Research (Proteomic, Genomic, Cell-based, Capillary), Manufacturing), End User (Pharma, Hospital) - Global Forecast to 2028

Report Code AST 7541
Published in Oct, 2024, By MarketsandMarkets™

Microfluidics Market by Product (Devices, Components (Chip, Sensor, Pump, Valve)), Application (IVD (POC, Clinical, Veterinary), Research, Manufacturing, Therapeutics), End User (Hospital, Diagnostic Center, Academic Institutes) & Region - Global Forecast to 2026

Report Code AST 7541
Published in Sep, 2023, By MarketsandMarkets™

Microfluidics Market by Product (Devices, Components (Chip, Sensor, Pump, Valve)), Application (IVD (POC, Clinical, Veterinary), Research, Manufacturing, Therapeutics), End User (Hospital, Diagnostic Center, Academic Institutes) - Global Forecast to 2026

Report Code AST 7541
Published in Sep, 2021, By MarketsandMarkets™

Microfluidics Market by Product (Devices, Components (Chips, Sensors, Pump, Valves, and Needles), Application (IVD [POC, Clinical, Veterinary], Research, Manufacturing, Therapeutics), End User and Region - Global Forecast to 2025

Report Code AST 7541
Published in May, 2020, By MarketsandMarkets™

Microfluidics Market by Application (Genomics, Proteomics, Capillary Electrophoresis, IVD (POC, Clinical Diagnostics), Drug Delivery, Microreactor, Lab Tests), Component (Chips, Pump, Needle), Material (Polymer, Glass, Silicon) - Global Forecast to 2023

Report Code MD 4809
Published in Mar, 2018, By MarketsandMarkets™

Microfluidics Market by Component (Microfluidic Chips, Micropump, Microneedle), Material (Polymer, Glass, Silicon), Application (Genomics, Proteomics, Capillary Electrophoresis, POC, Clinical, Environmental, Drug Delivery) - Global Forecast to 2021

Report Code MD 4809
Published in Dec, 2016, By MarketsandMarkets™

Microfluidics Market by Material (Polymer, Glass, Silicon) Application (Pharmaceutical (Genomics, Proteomics, Capillary Electrophoresis) Diagnostic (POC, Clinical, Environmental, Industrial) Drug Delivery (Inhaler, Micropump)) - Global Forecast to 2020

Report Code BT 3517
Published in Jun, 2015, By MarketsandMarkets™

Microfluidics Market by Material (Polymer, Glass, Silicon) Application (Pharmaceutical (Genomics, Proteomics, Capillary Electrophoresis) Diagnostic (POC, Clinical, Environmental, Industrial) Drug Delivery (Inhaler, Micropump)) - Global Forecast to 2020

Report Code BT 3517
Published in Jan, 2011, By MarketsandMarkets™

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Microfluidics Market

Farrah

May, 2022

Which material segment led the global microfluidics market?.

Kahlill

May, 2022

Which application accounted for the largest microfluidics market share?.

Alex

Nov, 2022

Which technology accounted for the highest share in the microfluidics market?.

James

Nov, 2022

What is the global microfluidics market's expected compound annual growth rate during the forecast period of 2022-2030?.

Philip

Mar, 2022

Which are the key challenges faced by global players of the Microfluidics Market?.

+1-888600-6441

Corporate Office Hours

+1-888600-6441

US/Can Toll Free

+44-800-368-9399

UK Office Hours

©2024 Marketsandmarkets Research Private Ltd. All Rights Reserved.

DMCA.com Protection Status